Related Experiment Video
Updated: Apr 23, 2026

10:31
Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
12.6K
Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study
H Isomoto1, S Shikuwa, N Yamaguchi
1Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. hajimei2002@yahoo.co.jp
Gut
|November 13, 2008
Summary
Endoscopic submucosal dissection (ESD) offers en bloc removal for early gastric cancer (EGC). Achieving curative resection via ESD significantly reduces recurrence, leading to excellent long-term survival rates.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Endoscopic Procedures
Background:
- Endoscopic submucosal dissection (ESD) allows en bloc resection of early gastric cancer (EGC), but long-term outcomes are not well-established.
- Conventional endoscopic mucosa resection has limitations compared to ESD for EGC.
- Assessing the long-term clinical outcomes of ESD for EGC is crucial.
Purpose of the Study:
- To evaluate tumour recurrence and survival rates in patients with EGC treated with ESD.
- To determine the factors influencing curative resection and complications after ESD.
- To assess the long-term prognosis of EGC following ESD treatment.
Main Methods:
- ESD was performed on 551 patients with 589 EGC lesions meeting expanded criteria.
- Follow-up included endoscopic surveillance and metastatic surveys for a median of 30 months (range 6-89 months).
- Outcomes assessed included en bloc resection rate, curative resection rate, complications, and survival rates.
Main Results:
- En bloc resection was achieved in 94.9% of lesions; larger lesions had a higher risk of piecemeal resection.
- A curative resection rate of 94.7% was achieved, with en bloc resection being the sole significant predictor of curability.
- Patients with non-curative resections experienced more local recurrence. The 5-year overall and disease-specific survival rates were 97.1% and 100%, respectively.
Conclusions:
- Precise curability assessment and successful en bloc resection are key to reducing tumour recurrence after ESD.
- The prognosis for EGC patients treated with ESD appears excellent.
- Further extended follow-up studies are recommended to confirm these long-term outcomes.

